Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5475507 | PMC |
http://dx.doi.org/10.5946/ce.2016.108 | DOI Listing |
Clin Endosc
May 2017
Department of Gastroenterology, Hospital Professor Doutor Fernando Fonseca, Amadora, Portugal.
Eur J Gastroenterol Hepatol
February 2009
Department of Clinical Medicine and Hepatology, GI Endoscopy Unit, University Campus Bio-Medico of Rome, Rome, Italy.
The most important systemic etiological factors for portal thrombosis are the thrombophilic conditions associated with myeloproliferative disorders (MPDs), either clinically manifest or so-called 'occult'. Latest studies have revealed a strong association between MPDs and a somatic point mutation (V617F) of the tyrosine kinase Janus kinase2. The 'pseudo-cholangiocarcinoma sign' is a well described radiological finding related to portal cavernoma.
View Article and Find Full Text PDFWorld J Gastroenterol
February 2006
Hacettepe University Faculty of Medicine, Department of Gastroenterology, 06100 Sihhiye, Ankara, Turkey.
The thrombophilia which can be either congenital or acquired in adult life has major implications in the abdominal vessels. The resulting portal vein thrombosis, Budd-Chiari syndrome and mesenteric vein thrombosis have a variety of consequences ranging from acute abdomen to chronic hepatomegaly and even totally asymptomatic patient in whom the only finding is pancytopenia. The complications like esophageal varices, portal gastropathy, ascites, severe hypersplenism, liver failure requiring liver transplantation are well known.
View Article and Find Full Text PDFJ Pediatr Gastroenterol Nutr
October 2001
Department of Pediatric Surgery, Hacettepe University Medical Faculty, Ankara, Turkey.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!